Two Sigma Advisers’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.44M | Sell |
123,500
-8,900
| -7% | -$320K | 0.01% | 782 |
|
|
2025
Q1 | $5.22M | Buy |
132,400
+121,700
| +1,137% | +$4.8M | 0.01% | 773 |
|
|
2024
Q4 | $322K | Sell |
10,700
-214,800
| -95% | -$6.47M | ﹤0.01% | 1953 |
|
|
2024
Q3 | $5.27M | Buy |
225,500
+59,400
| +36% | +$1.39M | 0.01% | 690 |
|
|
2024
Q2 | $2.95M | Buy |
+166,100
| New | +$2.95M | 0.01% | 991 |
|
|
2023
Q4 | – | Sell |
-951,200
| Closed | -$7.95M | – | 2642 |
|
|
2023
Q3 | $7.95M | Buy |
951,200
+218,600
| +30% | +$1.83M | 0.02% | 554 |
|
|
2023
Q2 | $18.2M | Buy |
732,600
+209,000
| +40% | +$5.19M | 0.05% | 324 |
|
|
2023
Q1 | $7.87M | Buy |
523,600
+176,300
| +51% | +$2.65M | 0.02% | 631 |
|
|
2022
Q4 | $4.11M | Buy |
347,300
+142,600
| +70% | +$1.69M | 0.01% | 861 |
|
|
2022
Q3 | $1.21M | Buy |
204,700
+55,300
| +37% | +$327K | ﹤0.01% | 1427 |
|
|
2022
Q2 | $635K | Buy |
149,400
+69,100
| +86% | +$294K | ﹤0.01% | 1821 |
|
|
2022
Q1 | $764K | Buy |
+80,300
| New | +$764K | ﹤0.01% | 1781 |
|
|
2021
Q1 | – | Sell |
-7,300
| Closed | -$380K | – | 2722 |
|
|
2020
Q4 | $380K | Buy |
+7,300
| New | +$380K | ﹤0.01% | 1967 |
|
|
2019
Q2 | – | Sell |
-45,200
| Closed | -$363K | – | 2433 |
|
|
2019
Q1 | $363K | Sell |
45,200
-10,600
| -19% | -$85.1K | ﹤0.01% | 1923 |
|
|
2018
Q4 | $229K | Buy |
55,800
+12,800
| +30% | +$52.5K | ﹤0.01% | 2087 |
|
|
2018
Q3 | $241K | Sell |
43,000
-9,100
| -17% | -$51K | ﹤0.01% | 2031 |
|
|
2018
Q2 | $685K | Buy |
52,100
+21,400
| +70% | +$281K | ﹤0.01% | 1785 |
|
|
2018
Q1 | $436K | Buy |
+30,700
| New | +$436K | ﹤0.01% | 1866 |
|
|
2017
Q4 | – | Sell |
-10,200
| Closed | -$121K | – | 2371 |
|
|
2017
Q3 | $121K | Sell |
10,200
-2,100
| -17% | -$24.9K | ﹤0.01% | 2107 |
|
|
2017
Q2 | $124K | Buy |
+12,300
| New | +$124K | ﹤0.01% | 2167 |
|